Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?

被引：3
|
作者：
Scagliotti, G. V. [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, S Luigi Hosp Reg Gozole 10, I-10043 Turin, Italy
[2] S Luigi Hosp, Thorac Oncol Unit, Turin, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 06期
关键词：
docetaxel; non-small-cell lung cancer; schedule; survival; toxicity;
D O I：
10.1038/ncponc0510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：294 / 295
页数：2
相关论文
共 50 条
  • [41] WEEKLY VINORELBINE IN ELDERLY PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    COLLEONI, M
    GAION, F
    NELLI, P
    COLMELLERE, GM
    MANENTE, P
    TUMORI, 1994, 80 (06) : 448 - 452
  • [42] Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer
    Ramalingam, Suresh
    Perry, Michael C.
    La Rocca, Renato V.
    Rinaldi, David
    Gable, Preston S.
    Tester, William J.
    Belani, Chandra P.
    CANCER, 2008, 113 (03) : 542 - 546
  • [43] A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients
    Ohe, Y
    Niho, S
    Kakinuma, R
    Kubota, K
    Ohmatsu, H
    Goto, K
    Nokihara, H
    Kunitoh, H
    Saijo, N
    Aono, H
    Watanabe, K
    Tango, M
    Yokoyama, A
    Nishiwaki, Y
    ANNALS OF ONCOLOGY, 2004, 15 (01) : 45 - 50
  • [44] Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy
    van Zyp, Noelle van der Voort
    Hashimzadah, Masoma
    Kouwenhoven, Erik
    Liskamp, Carmen
    Gadellaa-van Hooijdonk, Christa
    Pouw, Ellen
    Belderbos, Jose
    Maas, Klaartje
    van de Vaart, Paul
    Mast, Mirjam
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 36 : 70 - 76
  • [45] Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Gerber, David E.
    Spigel, David R.
    Giorgadze, David
    Shtivelband, Mikhail
    Ponomarova, Olga V.
    Shan, Joseph S.
    Menander, Kerstin B.
    Belani, Chandra P.
    CLINICAL LUNG CANCER, 2016, 17 (03) : 169 - 176
  • [46] A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
    Tabernero, J
    Climent, MA
    Lluch, A
    Albanell, J
    Vermorken, JB
    Barnadas, A
    Antón, A
    Laurent, C
    Mayordomo, JI
    Estaun, N
    Losa, I
    Guillem, V
    Garcia-Conde, J
    Tisaire, JL
    Baselga, J
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1358 - 1365
  • [47] Weekly versus 2-weekly versus 3-weekly docetaxel to treat metastatic castration-resistant prostate cancer
    Yuk, Hyeong Dong
    Kim, Miso
    Keam, Bhumsuk
    Ku, Ja Hyeon
    Kwak, Cheol
    Jeong, Chang Wook
    PROSTATE INTERNATIONAL, 2024, 12 (04) : 219 - 223
  • [48] A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Jiang, Haiping
    Zhang, Xiaochen
    Chen, Jing
    Zhang, Ling
    Xiong, Jianping
    Zhong, Lin
    Yu, Feng
    Qian, Jiong
    Yu, Lanfang
    Wang, Xiaoting
    Shi, Genming
    Deng, Jing
    Xu, Nong
    JOURNAL OF THORACIC DISEASE, 2014, 6 (02) : 79 - 85
  • [49] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Jiang, Lian
    Wang, Dao-yuan
    Zhu, Zhi-hua
    Tang, Liang-fa
    Hou, Xin-heng
    Zhao, Hong-da
    Xie, Zheng
    Wang, Dan-feng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 449 - 453
  • [50] Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
    Park, Se Hoon
    Hong, Junshik
    Kim, Young Saing
    Kim, Yujin
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    LUNG CANCER, 2008, 62 (01) : 72 - 77
12345